5 7 8 9 mediaplanningguide - u.s. pharmacist – the … pharmacy, as well as pharmacy leaders in...

9
Editorial / Circulation Information 2 Publication Information 3 2018 Editorial Calendar Closing Dates 4 Digital Websites 5 • uspharmacist.com • Power-Pak Website Digital Opportunities 6 • e-Mail/Newsletter • eFLASH • Weekly News Update • Next Issue eFLASH Additional Advertising / Subscription Information 7 ROB Ad Specifications 8 Contact Information 9 2018 MediaPlanningGuide THE PHARMACIST’S JOURNAL OF CLINICAL EXCELLENCE www.uspharmacist.com Mission / Vision Statement U.S. Pharmacist is committed to providing pharmacists with the highest quality clinical information. Our journal and programs, in both print and digital formats, will continue to deliver “need to know” information, relevant to the clinical aspects of today’s pharmacy practice, with the goal of improving patient care.

Upload: ngophuc

Post on 01-Apr-2018

216 views

Category:

Documents


2 download

TRANSCRIPT

Editorial / Circulation Information 2

Publication Information 3

2018 Editorial Calendar Closing Dates 4

Digital Websites 5 • uspharmacist.com • Power-Pak Website

Digital Opportunities 6 • e-Mail/Newsletter • eFLASH • Weekly News Update • Next Issue eFLASH

Additional Advertising / Subscription Information 7

ROB Ad Specifications 8

Contact Information 92018

MediaPlanningGuide

THE PHARMACIST’S JOURNAL OF CLINICAL EXCELLENCE

w w w . u s p h a r m a c i s t . c o m

Mission / Vision StatementU.S. Pharmacist is committed to providing pharmacists with the highest quality clinical information. Our journal and programs, in both print and digital formats, will continue to deliver “need to know” information, relevant to the clinical aspects of today’s pharmacy practice, with the goal of improving patient care.

2Publisher • Addie Blackburn • (201) 687-0813 • [email protected]

National Account Manager • Stela Salillari • (609) 781-5843 • [email protected] & Marketing Coordinator • Deborah Mortara • (201) 623-0990 • [email protected]

Origin of EditorialOf the articles published in U.S. Pharmacist, 90% are solicited and 10% are unsolicited. All manuscripts submitted are blind peer reviewed by pharmacists with expertise in the subject of the article.

Editorial Advisory BoardThe Editorial Advisory Board consists of pharmacists in a variety of practice settings, including community, consultant, and health-system pharmacy, as well as pharmacy leaders in academia, industry, and national associations. The Board contributes knowledge of cutting-edge advances to the profession via U.S. Pharmacist.

U.S. Pharmacist Provides Pertinent Editorial to Pharmacy Practitioners• Accredited Continuing Education • Generic Trends • TechRx• Consult Your Pharmacist • Clinical News Digest • Contemporary Compounding• Pharmacy Law • TrendWatch • Senior Care• Industry News • What’s News • Diagnostic Spotlight• Patient Teaching Aids • Pharmacy Focus • Cancer and Aids News

Average Ad/Editorial Ratio 45% / 55%Specialty Pharmacy, Oncology/Hematology Supplement 40% / 60%Generic Drug Review Supplement 40% / 60%

Circulation Information

Direct request circulation

100% direct request from individual pharmacists and 0% from recipient’s company

100% of the copies are mailed by name and title and/or function.

Mailed to pharmacists in 50 states in the following practice settings:

• Independent retail and chain store pharmacies operating prescription departments

• Health systems pharmacies• Nursing home pharmacies• Department stores and discount stores operating

prescription pharmacies• Supermarkets operating prescription pharmacies• Drug purchasing headquarters, including discount stores

and supermarkets• Drug wholesalers, colleges, associations, government,

pharmacy students, HMOs, manufacturers, and others allied to the field

2018 circulation is approximately 170,000See our latest BPA Statement for exact circulation information. CLICK HERE for full BPA report.

HMO 1%

U.S. Pharmacist Business/Occupational Breakout

of Circulation June 2017

Chain 55%

Independent 19%

Health System

21% Consultant Pharmacists 1%

Drug Purchasing

Headquarters 2%

Source: BPA Worldwide, June 2017

Specialty Pharmacy 1%

3Publisher • Addie Blackburn • (201) 687-0813 • [email protected]

National Account Manager • Stela Salillari • (609) 781-5843 • [email protected] & Marketing Coordinator • Deborah Mortara • (201) 623-0990 • [email protected]

* Health Systems rates apply.† Consult your sales representative.‡ National rates apply.

May 2017

THE PHARMACIST’S JOURNAL OF CLINICAL EXCELLENCE

w w w . u s p h a r m a c i s t . c o m

Pertussis on the Rise

Approaching Nocturnal Enuresis

Health Systems EditionManaging

Hypophosphatasia

Diagnosing & Treating

Wolman’s Disease

2 CE Credits

Mumps and the Importance of Vaccination

National EditionThe National Edition of U.S. Pharmacist is mailed monthly to pharmacists in all practice settings: retail (independent and chain), hospital, HMO, clinical, and consultant pharmacists. The 170,000 circulation also includes health care buyers at chain headquarters and drug wholesalers.

Health Systems EditionU.S. Pharmacist Health Systems Edition is mailed monthly to approximately 38,000 practicing pharmacists comprising hospital directors, staff and clinical pharmacists, HMO chief pharmacists, and consultant pharmacists. This peer-reviewed publication provides pharmacists with features and departments that address the pharmacy needs for acute patient care, long-term patient care, and outpatient pharmacy care.

Special Supplements

Specialty Pharmacy, Oncology & Hematology– February, May, July, November*

The Journal of Specialty Pharmacy, Oncology & Hematology Supplement is published 4 times a year – February, May, July, November – to 38,000 hospital, consultant, clinical, and HMO pharmacists. This is a peer-reviewed clinical publication that addresses pharmacy care for oncology and hematology patients.

Continuing education sponsorships are available for this specialized publication.

Generic Drug Review–June†Polybagged and mailed to 148,000 practicing pharmacists.

Published in June, the Generic Drug Review Supplement provides editorial opportunities that allow your company to spotlight:• Reputation and history• Management team and philosophy• Capabilities and current directions

New Drug Review–October‡

• Polybagged and mailed to 148,000 practicing pharmacists• Detailed descriptions of newly approved medications important to community

and health system pharmacists• Includes clinical and pharmacologic profiles, chemical structures, drug interactions,

adverse reactions, and key precautions and warnings

July 2017Supplement to

16 Two New Medications for Severe Eosinophilic Asthma

20 Antifungal Prophylaxis for Immunocompromised Patients

24 Hemophilia Review

ONCOLOGY &HEMATOLOGY

SPECIALTY PHARMACYThe Journal of

SUPPLEMENT TO U.S. PHARMACIST

COMPREHENSIVE OVERVIEW OF THE INDUSTRY JUNE 2017

Generic Drug Review

© gettyimages.com / JobsonHealthcare

The peer-reviewed articles focus on providing practical information for managing patients’ drug therapies, initiating preventive care, and improving treatment outcomes. Features and departments address Rx and OTC products, alternative and complementary therapies, and home care products such as test kits and monitors.

Continuing Education is featured in every issue.

Contact

Sales Representative

for Rate Information

4Publisher • Addie Blackburn • (201) 687-0813 • [email protected]

National Account Manager • Stela Salillari • (609) 781-5843 • [email protected] & Marketing Coordinator • Deborah Mortara • (201) 623-0990 • [email protected]

2018 Editorial Calendar Material Main Space Due Editorial Consult Your Pharmacy Month Reservation Date Focus Pharmacist Focus SupplementJanuary December 11 December 18 Neurological Cough & Cold 2017 2017

February January 10 January 17 Cardiovascular Anticoagulants Journal of Specialty 2018 2018 Pharmacy, Oncology/ Hematology

March February 9 February 16 Pain Eye & Ear 2018 2018 Management

April March 9 March 16 Infectious Pediatric 2018 2018 Disease

May April 10 April 17 Pediatric & Allergies Journal of Specialty 2018 2018 Adolescent Pharmacy, Oncology/ Hematology

June May 10 May 17 Dermatology Rheumatlogy Generic Drug Review 2018 2018

July June 8 June 15 Respiratory In Pharmacy 2018 2018 Vaccines

August July 10 July 17 Men's Health Dental/Altern- Journal of Specialty 2018 2018 ative Medicines/ Pharmacy, Oncology/ Veterinary Hematology

September August 10 August 17 Women's Oral 2018 2018 Health Contraception

October September 10 September 17 Diabetes Immunology New Drugs Review 2018 2018

November October 10 October 17 Mental Influenza Journal of Specialty 2018 2018 Health Pharmacy, Oncology/ Hematology

December November 9 November 16 Gastroenterologic 2018 2018

2018 Bonus Distribution

Issue Conference Location DateJanuary GPhA Annual Meeting Orlando, FL February 12-14

March APhA Annual Meeting Nashville, TN March 16-19

April NACDS Annual Meeting Palm Beach, FL April 21-24

August NACDS Total Store Expo Denver, CO August 25-28

September NCPA Annual Convention Boston, MA October 6-10

November ASHP Mid-Year Meeting Anaheim, CA December 2-6

Contact

Sales Representative

for Rate Information

5Publisher • Addie Blackburn • (201) 687-0813 • [email protected]

National Account Manager • Stela Salillari • (609) 781-5843 • [email protected] & Marketing Coordinator • Deborah Mortara • (201) 623-0990 • [email protected]

www.uspharmacist.com

Postgraduate Healthcare Education, LLC (PHE) delivers Power-Pak C.E. continuing educational programs to pharmacists, pharmacy technicians, and all other medical personnel in order to maintain and improve their knowledge and skill. Utilizing a variety of educational vehicles, PHE produces both live and enduring material lessons that are constantly evaluated and praised for their timeliness and relevance to the professionals they serve.

For more information and pricing, contact your U.S. Pharmacist sales representative.

www.powerpak.com

digital

USPharmacist.com provides pharmacists with all of the content from the print journal and additional online-only content including news and video content.

Online departments include:

• Pharmacy Practice – with the latest information by pharmacist practice setting (health-system, compounding, etc.)

• Diseases – content sections with U.S. Pharmacist articles, CE, and news related to the therapeutic category

• Publications – full digital archive of U.S. Pharmacist digital journal, Patient Teaching Aids and journal supplements, back to 2006

Average Monthly MetricsSessions: 147,319 (101,316 US Only)Users: 119,004 (80,271 US Only)Page views: 224,734 (81,496 US Only)Time on site: 0:01:52 (0:02:03 US Only)Mobile/Tablet: 42.8% (62.3% US Only)Source: Google Analytics; Average traffic Jan-Jun 2017

728 x 90

160 x

600

300 x 250

728 x 90

160 x

600

300 x 250

Advertiser/Agency RequirementsNo inventory will be held without a signed insertion order. Insertion order must include flight dates and special instructions.

All contracts hold a 30-day cancellation policy, unless FDA directive to suspend campaign is provided to U.S. Pharmacist.

U.S. Pharmacist reserves the right to approve and reject all ad creative that will run on USPharmacist.com. U.S. Pharmacist reserves the right to change out supplied creative if Advertiser's preferred creative malfunctions. Advertiser will be notified to send new creative tags, if desired. Advertiser may decide to forfeit inventory.

Missed or Incorrect Ads U.S. Pharmacist is not responsible for incidental or consequential damages for errors in displaying an ad or for failure to publish an ad. Should U.S. Pharmacist fail to publish an accepted ad for which an insertion order was received, U.S. Pharmacist will adjust advertiser’s/agency’s account accordingly, and such adjustment shall be the advertisers sole remedy.

Personally-Identifiable Information (PII) Collection No Advertising shall include any pixels, tags, Flash containers or other type of information collection software code, nor place any beacons, cookies, or other information collection devices on the browsers of users.

Average Monthly MetricsSessions: 194,033 (186,163 US Only)Users: 81,730 (77,828 US Only)Page views: 2,319,719 (2,250,835 US Only)Time on site: 0:19:08 (0:19:21 US Only)Source: Google Analytics; Average traffic Jan-Jun 2017

6Publisher • Addie Blackburn • (201) 687-0813 • [email protected]

National Account Manager • Stela Salillari • (609) 781-5843 • [email protected] & Marketing Coordinator • Deborah Mortara • (201) 623-0990 • [email protected]

digital

e-Mail and e-Newsletter Circulation Information2018 e-mail and e-newsletter circulation is approximately 280,410.100% direct request circulation of pharmacy professionals, including pharmacists and pharmacy technicians• U.S. Pharmacist requestors who also have requested to receive e-mails from U.S. Pharmacist• CE test takers who have requested to receive e-mails from U.S. Pharmacist

U.S. Pharmacist eFLASHHighly Targeted Communications: The U.S. Pharmacist eFLASH offers advertisers a highly effective way to custom deliver their message to a qualified pharmacy audience.eFLASH features: calls to action, such as “Click here,” to prompt pharmacists to visit sponsors’ Websites—further increasing message exposure. In addition, sponsors benefit from their association with the trust and recognition inherent in the U.S. Pharmacist brand.24-Hour Turnaround • Great Open Rates • Metrics Available

U.S. Pharmacist Weekly News Update – 100% SOVReaders can stay abreast of important developments affecting pharmacists with U.S. Pharmacist’s Weekly News Update, a key source for keeping current in an ever-changing environment that is e-mailed to the entire U.S. Pharmacist list.The update features in-depth, authoritative analysis of clinical and regulatory news as well as links to background articles that enable readers to quickly gain insight into key trends.

In the Next Issue eTOC – 100% SOVReaders can preview the high-quality clinical content in soon-to-be mailed issues of U.S. Pharmacist with the In the Next Issue Newsletter. This timely e-TOC, which is emailed to their entire U.S. Pharmacist list, enables pharmacists to monitor and anticipate the latest clinical developments. In addition, the In the Next Issue Newsletter features links to popular and oftentimes provocative feature articles and departments from recent issues of U.S. Pharmacist,

General Ad Requirements (Apply to all ads):• Interest-Based Advertising (IBA): Include IBA self-regulation controls for ads using behavioral targeting (5 KB max file size)• Audio: Must be user-initiated. To allow for audio initiation in videos without player controls, a control may be included for

user to initiate audio.• Hotspot: Not to exceed 1/4 size of ad. Initiated when cursor rests on hotspot for at least 1 sec. Must NOT initiate audio.• Defining ad space: Ad unit content must be clearly distinguishable from normal webpage content (ad unit must have

clearly defined borders and not be confused with normal page content).• Max CPU: ad not to exceed 30% CPU usage during host-initiated execution.• Submission lead time: Minimum lead time for ad file submission is 6 days before campaign start.• Max number of host-initiated file requests: ad not to exceed 15 file requests during initial file load and host-initiated sub-

load. Unlimited file requests allowed after user-interaction.

General Notes:1. File weight calculation: All files for the ad (.html, .js, .css, images, etc.) must be included as part of the maximum file

weight calculation for all file load limits. Shared libraries are also included as part of the file weight calculation unless otherwise expempted . File weights are calculated after files have been compressed into gzip format.

2. Initial file load: Includes all assets and files necessary for completing first visual display of the Ad.3. Host-initiated subload: where allowed, additional files may load one second after the browser domContentLoadedEven-

tEnd event. The ad should be able to “listen” for the browser domContentLoadedEventEnd event before subsequent files beyond the initial max file size may be loaded.

4. User-initiated file size: Ads that allow additional file size for host-initiated subload also allow for unlimited file load after user-initiated interaction. User initiation is the willful act of a user to engage with an ad. Users may interact by clicking or tapping the ad, and/or rolling over an ad (or a portion of an ad).

Digital Ad Specifications: USPharmacist.com & PowerPak.com Expansion Expansion Ad Units Ad Expanded trigger to open trigger to close Expansion Stanard Max Animation Frame Accepted Formats Ad Unit (ie. 'click to open') (ie. 'click to close') Direction File Size File Size Limit Rate728x90 HTML5, JPG, GIF, 728x315 Rollover to open Click to close Down 200 KB 300KB 15 sec max Minimun 24 fsp Third Party Tags animation length for video160x600 HTML5, JPG, GIF, 600x600 Rollover to open Click to close Right 200 KB 300KB 15 sec max Minimun 24 fsp Third Party Tags animation length for video300x250 HTML5, JPG, GIF, 600x250 Rollover to open Click to close Left 200 KB 300KB 15 sec max Minimun 24 fsp Third Party Tags animation length for videoInterstitial HTML5, JPG, GIF, 300x250 to NA NA NA 200 KB 300KB Minimun 24 fsp for video 15 sec max length Third Party Tags 640x480 (unlimited user initiated) 1.1 MB additional file size allowed for host-initiated video Unlimited file size for user-initiated video

HTML Notes: HTML5 provides / introduces new options for developing ads. The IAB has developed “HTML5 for Digital Advertising” (http://www.iab.com/html5) to help ad designers provide ads in HTML5 unit that will perform more successfully across the display advertising ecosystem. Please review this document and adopt its recommendations to help improve HTML5 ad performance in the industry.

Other Rich Media Requirements/Restrictions (i.e. sound limitations, etc.) Retract Feature = Either Click to close/expand or Enable Mouse-Off Retraction

1.1 MB additional file size allowed for host-initiated video Unlimited files size for user-initiated video

7Publisher • Addie Blackburn • (201) 687-0813 • [email protected]

National Account Manager • Stela Salillari • (609) 781-5843 • [email protected] & Marketing Coordinator • Deborah Mortara • (201) 623-0990 • [email protected]

Additional Advertising Information

Please email Insertion order to [email protected] or Fax to: 201-604-6169 Sales & Marketing Coordinator Deborah Mortara (201) 623-0990

National Demographic/Geographic Ad RatesAdvertisements and inserts are accepted. Geographic regions are selected by zip code only. Minimum 30% of the national circulation. Amounts under 30% will be billed at the 30% rate.

Earned RatesEarned rates are based on the number of insertions in a 12-month calendar or fiscal period.

Advertising from U.S. Pharmacist and our supplements – Specialty Pharmacy, Oncology/Hematology, Generics and Diabetes – are combined to determine earned frequency.

Spread ads count as two insertions. Single-page and fractional-page ads are each counted as one insertion.

Agency Commission15% of gross on space, color, and premium rates. Commissions are calculated after earned discounts are deducted.

Split RunsRun of Book• Percent of circulation multiplied by the earned

black & white rate, plus color charges.• Add $1,000 for stop press, selection, and

handling charges (consult publisher).Furnished Inserts• Percent of circulation multiplied by the earned

black & white rate multiplied by the number of insert pages.

• Add $1,000 for binding, selection, and handling charges (consult publisher).

Requirements for Acceptance of AdvertisingInsertion orders are required for placement of ad space. The insertion order must include the name of the advertiser and product, indication of National, Health Systems, and supplements, issue date, size of ad unit, and color requirements. All ads and inserts should indicate positioning and “A” side, “B” side.

All orders are accepted subject to the terms and conditions in this media planning guide and will be executed to the best of U.S. Pharmacist’s ability.No conditions, printed or otherwise, appearing on contracts, orders, or copy instructions that conflict with

the publisher’s policies noted within this media planning guide shall be binding on U.S. Pharmacist.

Insertion orders are binding after closing date on parties placing the order; no cancellations are permitted after closing dates. U.S. Pharmacist disclaims all responsibility for copy changes made after closing dates without written agreement from U.S. Pharmacist.

U.S. Pharmacist reserves the unrestricted right to reject any advertising at any time after receipt of proofs of texts and illustrations. Advertorials that resemble U.S. Pharmacist editorial pages are prohibited.

Inadvertent failure by U.S. Pharmacist to publish an advertisement invalidates the insertion order for such an ad but will not affect any earned frequency discount.

Advertising pages are interspersed throughout the issue.

Classified AdvertisingInformation on advertising rates, closing dates, and production requirements can be obtained by contacting:KERH Group LLC PO Box 207 Parker Ford, PA 19457 Toll Free: 888-498-1490 E-mail: [email protected]

Agency Commission15% of gross on space, color, and premium rates. Commissions are calculated after earned discounts are deducted.

Subscription InformationOne-year subscription rate:• U.S.A. rate $63.00• Faculty and Pharmacy student rate $42.00• Canada/Mexico rate $87.00• Air mail to all other countries $170.00Single-issue rate $6.00

Reprint InformationReprints of any articles that appear in U.S. Pharmacist can be ordered by contacting Wright’s Media at 877-652-5295 or [email protected].

List RentalJennifer Felling Statlistics 69 Kenosia Avenue Danbury, CT 06810E-mail: [email protected] Tel: 203-778-8700 Fax: 203-778-4839

8Publisher • Addie Blackburn • (201) 687-0813 • [email protected]

National Account Manager • Stela Salillari • (609) 781-5843 • [email protected] & Marketing Coordinator • Deborah Mortara • (201) 623-0990 • [email protected]

Dimensions: AD UNIT NON-BLEED BLEED (1/8") TRIM Spread 14 1/2” x 10” 15 3/4” x 11” 15 1/2” x 10 3/4” Full Pg 7” x 10” 8” x 11” 7 3/4” x 10 3/4” 2/3 Pg Ver 4 5/8" x 10" 5 3/8" x 11" 5 1/8” x 10 3/4” 1/2 Pg Ver 3 1/2" x 10" 4 1/8" x 11" 3 7/8” x 10 3/4” 1/2 Pg Hor 7" x 5" 8" x 5 5/8" 7 3/4” x 5 3/8” 1/3 Pg 2 1/4" x 10" 2 7/8" x 11" 2 5/8” x 10 3/4” 1/4 Pg 3 1/2" x 5" 4 1/8" x 5 5/8" 3 7/8” x 5 3/8”

Preferred PDF/X1-a; High-resolution PDF File Format: with embedded fonts and images.

Accepted Packaged InDesign CS4 (or earlier) files. Please provide all ancillary files including fonts,

File Format: original InDesign and TIFF or EPS graphics (see details below). A digital color proof (Kodak Approval preferred) is required. Please preflight your files. Any files found to have problems with fonts, colors, or graphics will be returned for adjustment. Additional MAC work will be charged back to the agency or client.

Fonts: • Use only Postscript Type 1 fonts • Supply suitcases, screen fonts, and printer fonts as well as fonts embedded in graphics • Menu styled, Multiple Master, and True Type fonts are NOT accepted

Graphics: • Use only EPS and TIFF file formats • 800-1,200 dpi for line-work • No JPEG or LZW compression • Images must be CMYK, not RGB • 300 dpi for color and gray scale images • Place artwork at 100% • Do not nest EPS files within EPS flatten layers. Delete extra channels in Photoshop. • Resize and rotate images in their original application.

Colors: Convert all files to CMYK process unless a PMS color has been reserved and documented on the Ad Order.

Proofs: We require 1 digital proof (Kodak Approval preferred) from the digital file being delivered.

Line Screen • 4-COLOR: 133 Line Screen. Total density may not exceed 300% Density: • BLACK/WHITE, 2-COLOR: 120 Line Screen • Total density for 2-color may not exceed 170% and 1 color may be solid • Black/White cannot exceed 85%

Media Type: CD-ROM (MAC formatted)

Shipping Disks, Proofs, and Insertion Orders go to: Instructions: Jobson Medical Information LLC c/o U.S. Pharmacist – Production Department 440 Ninth Avenue, 14th Floor, New York, NY 10001 Production Manager: Mario Iannotta (212) 274-7008

FTP All files must be sent STUFFED. Send e-mail to [email protected] indicating Instructions: Advertiser, Ad Unit, Month, and Publication. Color proofs, as indicated above, must be supplied. Host: ftp.production.jobson.com User: jobsonclient Password: ftp!prod1 Directory: In/USP_Ads

Run of Book Ad SpecificationsJune 2017

THE PHARMACIST’S JOURNAL OF CLINICAL EXCELLENCE

w w w . u s p h a r m a c i s t . c o m

Resolving Drug-Induced Skin

Reactions2 CE Credits

Applying MTM to the Cardiovascular

PatientHealth Systems Edition

Addressing the Polypharmacy Conundrum

Implementing MTM for COPD

Managing Chronic Kidney Disease

With MTM

9

For your convenience, the U.S. Pharmacist 2018 Media Planning Guide is available online at www.uspharmacist.com/mediakit.

Jobson Medical Information LLC 160 Chubb Avenue, Suite 304

Lyndhurst, NJ 07071 Tel: (201) 623-0999 • Fax: (201) 604-6169

E-mail: [email protected] Website: www.uspharmacist.com

Publisher Addie Blackburn (201) 687-0813

[email protected]

National Account Manager Stela Salillari

(609) 781-5843 [email protected]

Sales & Marketing Coordinator Deborah Mortara

(201) 623-0990 [email protected]

Production Manager Mario Iannotta (212) 274-7008

[email protected]

Please Fax Insertion Orders To: 201-604-6169

Editor-in-Chief Robert Davidson (201) 623-0981

[email protected]

Senior Associate Editor Marjorie Borden (201) 623-0989

[email protected]

Associate Editor Moira Flaherty (201) 623-0930

[email protected]

Design Director Sharyl Sand Carow

(201) 623-0925 [email protected]